Construction of tissue microarrays from prostate needle biopsy specimens

被引:27
作者
Jhavar, S
Corbishley, CM
Dearnaley, D
Fisher, C
Falconer, A
Parker, C
Eeles, R
Cooper, CS
机构
[1] Inst Canc Res, Male Urol Canc Res Ctr, Sect Mol Carcinogenesis, Sutton SM2 5NG, Surrey, England
[2] Royal Marsden NHS Fdn Trust, Dept Acad Urol, London SW17 0QT, England
[3] Inst Canc Res, London SW17 0QT, England
[4] Royal Marsden NHS Fdn Trust, Dept Histopathol, London SW3 6JJ, England
[5] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England
关键词
prostate; cancer; needle biopsy; tissue microarray; immunohistochemistry;
D O I
10.1038/sj.bjc.6602726
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Needle biopsies are taken as standard diagnostic specimens for many cancers, but no technique exists for the high-throughput analysis of multiple individual immunohistochemical (IHC) markers using these samples. Here we present a simple and highly reliable technique for constructing tissue microarrays (TMAs) from prostatic needle biopsies. Serial sectioning of the TMAs, called 'Checkerboard TMAs', facilitated expression analysis of multiple proteins using IHC markers. In total, 100% of the analysed biopsies within the TMA both preserved their antigenicity and maintained their morphology. Checkerboard TMAs will allow the use of needle biopsies (i) alongside other tissue specimens (trans-urethral resection of prostates and prostatectomies in the case of prostate cancer) in clinical correlation studies when searching for new prognostic markers, and (ii) in a diagnostic context for assessing expression of multiple proteins in cancers from patients prior to treatment.
引用
收藏
页码:478 / 482
页数:5
相关论文
共 28 条
  • [21] Pusztai L, 2003, CLIN CANCER RES, V9, P2406
  • [22] Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer
    Rhodes, DR
    Sanda, MG
    Otte, AP
    Chinnaiyan, AM
    Rubin, MA
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (09) : 661 - 668
  • [23] Tissue Microarray sampling strategy for prostate cancer biomarker analysis
    Rubin, MA
    Dunn, R
    Strawderman, M
    Pienta, KJ
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (03) : 312 - 319
  • [24] Schraml P, 1999, CLIN CANCER RES, V5, P1966
  • [25] Core biopsies can be used to distinguish differences in expression profiling by cDNA microarrays
    Sotiriou, C
    Khanna, C
    Jazaeri, AA
    Petersen, D
    Liu, ET
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2002, 4 (01) : 30 - 36
  • [26] TAKAHASHI S, 1994, CANCER RES, V54, P3574
  • [27] Detection of prostate cancer and predicting progression: Current and future diagnostic markers
    Tricoli, JV
    Schoenfeldt, M
    Conley, BA
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (12) : 3943 - 3953
  • [28] Yao SL, 2002, J NATL CANCER I, V94, P958